Products

Linkjoy

Linkjoy: The Next Gen Link In Bio tool

linkjoy.page Creator Economy & Community / Creator Storefronts & Link-in-Bio

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$4.99/mo
Lower than 79% of peersNiche median $7.99/mo
Creators
Kathyrn
No social account linked
Launched
4mo ago
2026-07-14 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    A link-in-bio tool to unlock your growth

    Jul 14 · 4mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-06-25

KeywordMonthly volume
linj76.3K
linkjoy130
linkjoy bio link0
what is linkjoy0

Traffic data: Vaneform

Pricing

Basic
$4.99/mo
Pro
$9.99/mo

Trial: None · 2 paid tiers ($4.99–$9.99) · Observed 2026-11-06 · Source page

Entry price $4.99/mo, Lower than 79% of peers; “Creator Storefronts & Link-in-Bio” median is $7.99/mo.View pricing benchmark

Website snapshots

Indexed 2026-07-14

Key pages

Desktop & mobile archive
Home
linkjoy.page/ Snapshot 2026-11-06

Questions & evidence

How much does Linkjoy cost?
Basic: $4.99/mo; Pro: $9.99/mo. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Linkjoy get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Linkjoy and what platforms does it support?
Linkjoy is catalogued under Creator Storefronts & Link-in-Bio: Linkjoy: The Next Gen Link In Bio tool. Supported platforms: Web.

Related products in this category

Creator Economy & Community / Creator Storefronts & Link-in-Bio

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.